Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CTGF/CCN2 C-Terminus Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 6 publications
Supplier: R&D Systems MAB660100
This item is not returnable.
View return policy
Description
CTGF/CCN2 Monoclonal specifically detects CTGF/CCN2 in Human samples. It is validated for Immunohistochemistry.Specifications
CTGF/CCN2 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CCN2, CCN2IGFBP-8, connective tissue growth factor, CTGRP, Fisp12, HCS24, Hypertrophic chondrocyte-specific protein 24, IBP-8, IGF-binding protein 8, IGFBP-8, IGFBP8CCN family member 2, Insulin-like growth factor-binding protein 8, MGC102839, NOV2 | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
1490 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Immunohistochemistry | |
88430 | |
Immunohistochemistry 8-25 ug/mL | |
NP_001892.1 | |
CTGF | |
E. coli-derived recombinant human CTGF Glu247-Ala349 Accession # NP_001892.1 | |
100 μg | |
Primary | |
Detects human CTGF C-teriminal peptide in direct ELISAs. Does not cross-react with recombinant human (rh) LDGF, rhNOV, rhPDGF, rhPlGF, rhVEGF 206 rhVEGF-B 186 rhVEGF-C, rhVEGF-D, or rhWISP-1. | |
Human | |
Ascites |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?
Provide Content Correction